메뉴 건너뛰기




Volumn 62, Issue SUPPL. 1, 2004, Pages 93-100

Recombinant human insulin-like growth factor I (IGF-I): Risks and benefits of normalizing blood IGF-I concentrations

Author keywords

Growth hormone; Insulin; Insulin like growth factor I; Insulin like growth factor I deficiency; Primary insulin like growth factor I deficiency; Recombinant; Risk benefit; Safety

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; INSULIN ASPART; PROLACTIN RECEPTOR; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN B; SOMATOMEDIN C;

EID: 17244373148     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080766     Document Type: Conference Paper
Times cited : (27)

References (57)
  • 2
    • 0037131385 scopus 로고    scopus 로고
    • Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved
    • Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A: Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 2002;277:39684-39695.
    • (2002) J Biol Chem , vol.277 , pp. 39684-39695
    • Pandini, G.1    Frasca, F.2    Mineo, R.3    Sciacca, L.4    Vigneri, R.5    Belfiore, A.6
  • 4
    • 0033305597 scopus 로고    scopus 로고
    • The essential role of IGF-I: Lessons from the long-term study and treatment of children and adults with Laron syndrome
    • Laron Z: The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab 1999;84:4397-4404.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 4397-4404
    • Laron, Z.1
  • 5
    • 1642328411 scopus 로고    scopus 로고
    • Toward a molecular basis for idiopathic short stature
    • Rosenfeld RG, Hwa V: Toward a molecular basis for idiopathic short stature. J Clin Endocrinol Metab 2004;89:1066-1067.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 1066-1067
    • Rosenfeld, R.G.1    Hwa, V.2
  • 6
    • 0035175162 scopus 로고    scopus 로고
    • Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth
    • Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A: Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 2001;229:141-162.
    • (2001) Dev Biol , vol.229 , pp. 141-162
    • Lupu, F.1    Terwilliger, J.D.2    Lee, K.3    Segre, G.V.4    Efstratiadis, A.5
  • 8
    • 0042173160 scopus 로고    scopus 로고
    • Serum insulin-like growth factor I: Tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men
    • Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D: Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Cancer Res 2003;63:3991-3994.
    • (2003) Cancer Res , vol.63 , pp. 3991-3994
    • Woodson, K.1    Tangrea, J.A.2    Pollak, M.3    Copeland, T.D.4    Taylor, P.R.5    Virtamo, J.6    Albanes, D.7
  • 9
    • 0035743238 scopus 로고    scopus 로고
    • Determination of insulin-like growth factor I in children: Normal values and clinical use
    • Juul A: Determination of insulin-like growth factor I in children: normal values and clinical use. Horm Res 2001;55(suppl 2):94-99.
    • (2001) Horm Res , vol.55 , Issue.2 SUPPL. , pp. 94-99
    • Juul, A.1
  • 10
    • 0030656605 scopus 로고    scopus 로고
    • Pioneering recombinant growth hormone manufacturing: Pounds produced per mile of height
    • Cronin MJ: Pioneering recombinant growth hormone manufacturing: pounds produced per mile of height. J Pediatr 1997;131:S5-S7.
    • (1997) J Pediatr , vol.131
    • Cronin, M.J.1
  • 11
    • 0035012283 scopus 로고    scopus 로고
    • Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the Growth Hormone Research Society
    • Growth Hormone Research Society: Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 2001;86:1868-1870.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 1868-1870
  • 12
    • 0031846497 scopus 로고    scopus 로고
    • Effect of long-term recombinant growth hormone therapy in children - The National Cooperative Growth Study, USA, 1985-1994
    • Root AW, Kemp SF, Rundle AC, Dana K, Attie KM: Effect of long-term recombinant growth hormone therapy in children - the National Cooperative Growth Study, USA, 1985-1994. J Pediatr Endocrinol Metab 1998;11:403-412.
    • (1998) J Pediatr Endocrinol Metab , vol.11 , pp. 403-412
    • Root, A.W.1    Kemp, S.F.2    Rundle, A.C.3    Dana, K.4    Attie, K.M.5
  • 13
    • 0035742586 scopus 로고    scopus 로고
    • Safety in growth hormone replacement therapy: A matter of varied responsiveness?
    • 200
    • Wilton P: Safety in growth hormone replacement therapy: a matter of varied responsiveness? Horm Res 200;55(suppl 2):61-64.
    • Horm Res , vol.55 , Issue.2 SUPPL. , pp. 61-64
    • Wilton, P.1
  • 14
    • 0036884998 scopus 로고    scopus 로고
    • LWPES Executive Committee and the LWPES Drug and Therapeutics Committee: Growth hormone treatment and neoplasia - Coincidence or consequence?
    • Sperling MA, Saenger PH, Hintz R, Wilson T, Rose SR; Lawson Wilkins Pediatric Endocrine Society. LWPES Executive Committee and the LWPES Drug and Therapeutics Committee: Growth hormone treatment and neoplasia - coincidence or consequence? J Clin Endocrinol Metab 2002;87:5351-5352.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 5351-5352
    • Sperling, M.A.1    Saenger, P.H.2    Hintz, R.3    Wilson, T.4    Rose, S.R.5
  • 15
    • 84921702893 scopus 로고    scopus 로고
    • FDA approves growth hormone for short children
    • FDA approves growth hormone for short children (editorial). Child Health Alert 2003;21:4.
    • (2003) Child Health Alert , vol.21 , pp. 4
  • 19
    • 0025333249 scopus 로고
    • Premature mortality due to cardiovascular disease in hypopituitarism
    • Rosen T, Bengtsson BA: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-288.
    • (1990) Lancet , vol.336 , pp. 285-288
    • Rosen, T.1    Bengtsson, B.A.2
  • 20
    • 0346095213 scopus 로고    scopus 로고
    • Acromegaly and colorectal cancer: A comprehensive review of epidemiology, biological mechanisms, and clinical implications
    • Renehan AG, O'Connell J, O'Halloran D, Shanahan F, Potten CS, O'Dwyer ST, Shalet SM: Acromegaly and colorectal cancer: A comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res 2003;35:712-725.
    • (2003) Horm Metab Res , vol.35 , pp. 712-725
    • Renehan, A.G.1    O'Connell, J.2    O'Halloran, D.3    Shanahan, F.4    Potten, C.S.5    O'Dwyer, S.T.6    Shalet, S.M.7
  • 21
    • 0031759850 scopus 로고    scopus 로고
    • Mortality and cancer incidence in acromegaly: A retrospective cohort study
    • United Kingdom Acromegaly Study Group
    • Orme SM, McNally RJ, Cartwright RA, Belchetz PE: Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998;83:2730-2734.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 2730-2734
    • Orme, S.M.1    McNally, R.J.2    Cartwright, R.A.3    Belchetz, P.E.4
  • 22
    • 0035404392 scopus 로고    scopus 로고
    • Acromegaly and cancer: Not a problem?
    • Melmed S: Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 2001;86:2929-2934.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 2929-2934
    • Melmed, S.1
  • 23
    • 0034928043 scopus 로고    scopus 로고
    • Clinical perspective: Acromegaly and cancer: A problem
    • Jenkins PJ, Besser M: Clinical perspective: acromegaly and cancer: A problem. J Clin Endocrinol Metab 2001;86:2935-2941.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 2935-2941
    • Jenkins, P.J.1    Besser, M.2
  • 24
    • 0346732359 scopus 로고    scopus 로고
    • Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders
    • Mukherjee A, Monson JP, Jonsson PJ, Trainer PJ, Shalet SM; KIMS International Board: Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. J Clin Endocrinol Metab 2003;88:5865-5870.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 5865-5870
    • Mukherjee, A.1    Monson, J.P.2    Jonsson, P.J.3    Trainer, P.J.4    Shalet, S.M.5
  • 25
    • 0346725867 scopus 로고    scopus 로고
    • Nutrition, insulin, insulin-like growth factors and cancer
    • Giovannucci E: Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003;35:694-704.
    • (2003) Horm Metab Res , vol.35 , pp. 694-704
    • Giovannucci, E.1
  • 26
    • 0031454715 scopus 로고    scopus 로고
    • Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice
    • Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J: Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 1997;100:2744-2751.
    • (1997) J Clin Invest , vol.100 , pp. 2744-2751
    • Wennbo, H.1    Gebre-Medhin, M.2    Gritli-Linde, A.3    Ohlsson, C.4    Isaksson, O.G.5    Tornell, J.6
  • 28
    • 0032079677 scopus 로고    scopus 로고
    • Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice
    • Pravtcheva DD, Wise TL: Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice. J Exp Zool 1998;281:43-57.
    • (1998) J Exp Zool , vol.281 , pp. 43-57
    • Pravtcheva, D.D.1    Wise, T.L.2
  • 29
    • 0037434663 scopus 로고    scopus 로고
    • Transgenic overexpression of IGF-II induces spontaneous lung tumors: A model for human lung adenocarcinoma
    • Moorehead RA, Sanchez OH, Baldwin RM, Khokha R: Transgenic overexpression of IGF-II induces spontaneous lung tumors: A model for human lung adenocarcinoma. Oncogene 2003;22:853-857.
    • (2003) Oncogene , vol.22 , pp. 853-857
    • Moorehead, R.A.1    Sanchez, O.H.2    Baldwin, R.M.3    Khokha, R.4
  • 30
    • 0031053537 scopus 로고    scopus 로고
    • Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice
    • Chen NY, Chen WY, Striker LJ, Striker GE, Kopchick JJ: Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice. Endocrinology 1997;138:851-854.
    • (1997) Endocrinology , vol.138 , pp. 851-854
    • Chen, N.Y.1    Chen, W.Y.2    Striker, L.J.3    Striker, G.E.4    Kopchick, J.J.5
  • 31
    • 0023945744 scopus 로고
    • Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1
    • Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE: Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 1988;131:398-403.
    • (1988) Am J Pathol , vol.131 , pp. 398-403
    • Doi, T.1    Striker, L.J.2    Quaife, C.3    Conti, F.G.4    Palmiter, R.5    Behringer, R.6    Brinster, R.7    Striker, G.E.8
  • 32
    • 0029923352 scopus 로고    scopus 로고
    • The obese growth hormone (GH)-deficient dwarf rat: Body fat responses to patterned delivery of GH and insulin-like growth factor-I
    • Clark RG, Mortensen DL, Carlsson LM, Carlsson B, Carmignac D, Robinson IC: The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I. Endocrinology 1996;137:1904-1912.
    • (1996) Endocrinology , vol.137 , pp. 1904-1912
    • Clark, R.G.1    Mortensen, D.L.2    Carlsson, L.M.3    Carlsson, B.4    Carmignac, D.5    Robinson, I.C.6
  • 34
    • 0141755327 scopus 로고    scopus 로고
    • Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: Relative roles of growth hormone and IGF-1 in insulin resistance
    • Haluzik M, Yakar S, Gavrilova O, Setser J, Boisclair Y, LeRoith D: Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 2003;52:2483-2489.
    • (2003) Diabetes , vol.52 , pp. 2483-2489
    • Haluzik, M.1    Yakar, S.2    Gavrilova, O.3    Setser, J.4    Boisclair, Y.5    LeRoith, D.6
  • 35
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 36
    • 0033035850 scopus 로고    scopus 로고
    • Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes
    • RhIGF-I in IDDM Study Group
    • Thrailkill KM, Quattrin T, Baker L, Kuntze JE, Compton PG, Martha PM Jr: Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care 1999;22:585-592.
    • (1999) Diabetes Care , vol.22 , pp. 585-592
    • Thrailkill, K.M.1    Quattrin, T.2    Baker, L.3    Kuntze, J.E.4    Compton, P.G.5    Martha Jr., P.M.6
  • 38
    • 0041743158 scopus 로고    scopus 로고
    • Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization
    • Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR: Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 2003;111:1835-1842.
    • (2003) J Clin Invest , vol.111 , pp. 1835-1842
    • Kondo, T.1    Vicent, D.2    Suzuma, K.3    Yanagisawa, M.4    King, G.L.5    Holzenberger, M.6    Kahn, C.R.7
  • 39
    • 0037143639 scopus 로고    scopus 로고
    • Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: A population-based case-control study
    • Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T: Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: A population-based case-control study. Circulation 2002;106:939-944.
    • (2002) Circulation , vol.106 , pp. 939-944
    • Juul, A.1    Scheike, T.2    Davidsen, M.3    Gyllenborg, J.4    Jorgensen, T.5
  • 42
    • 0842291511 scopus 로고    scopus 로고
    • The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study
    • Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D: The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 2004;89:114-120.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 114-120
    • Laughlin, G.A.1    Barrett-Connor, E.2    Criqui, M.H.3    Kritz-Silverstein, D.4
  • 43
    • 0142056143 scopus 로고    scopus 로고
    • Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: The Framingham Heart Study
    • Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D, Wilson PW: Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 2003;139:642-648.
    • (2003) Ann Intern Med , vol.139 , pp. 642-648
    • Vasan, R.S.1    Sullivan, L.M.2    D'Agostino, R.B.3    Roubenoff, R.4    Harris, T.5    Sawyer, D.B.6    Levy, D.7    Wilson, P.W.8
  • 46
  • 47
    • 0034489209 scopus 로고    scopus 로고
    • A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly
    • Kalmijn S, Janssen JA, Pols HA, Lamberts SW, Breteler MM: A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab 2000;85:4551-4555.
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 4551-4555
    • Kalmijn, S.1    Janssen, J.A.2    Pols, H.A.3    Lamberts, S.W.4    Breteler, M.M.5
  • 50
    • 0034877472 scopus 로고    scopus 로고
    • IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming
    • Vickers MH, Ikenasio BA, Breier BH: IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming. Endocrinology 2001;142:3964-3973.
    • (2001) Endocrinology , vol.142 , pp. 3964-3973
    • Vickers, M.H.1    Ikenasio, B.A.2    Breier, B.H.3
  • 52
    • 0036031802 scopus 로고    scopus 로고
    • Novel activities of pro-IGF-I E peptides: Regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells
    • Kuo YH, Chen TT: Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells. Exp Cell Res 2002;280:75-89.
    • (2002) Exp Cell Res , vol.280 , pp. 75-89
    • Kuo, Y.H.1    Chen, T.T.2
  • 54
    • 17244369332 scopus 로고    scopus 로고
    • NovoLog product label. Available at http:// www.fda.gov/cder/foi/label/ 2000/209861bl.pdf. Accessed April 23, 2004.
  • 57


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.